Therapeutic Goods Administration

Part of the Health portfolio and a Federal authority, also called TGA

The Therapeutic Goods Administration is responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products.

63 requests
Make a request to this authority

(page 2)

Correspondence between the TGA and the AMA relating to electronic cigarettes
Response by Therapeutic Goods Administration to Mary Montagu on .

Refused.

Good afternoon Ms Montagu,   Please see attached decision letter regarding your request.   Regards David   Freedom of Information Thera...
Correspondence relating to electronic cigarettes (Australian Medical Association)
Response by Therapeutic Goods Administration to Mary Montagu on .

Refused.

Good afternoon Ms Montagu,   Please see attached decision letter regarding your request.   Regards David   Freedom of Information Thera...
Sars-Cov-2
Response by Therapeutic Goods Administration to Zaia D on .

Successful.

Dear Ms Daryoush Thank you for your email below dated 24 August 2021 in which you make the following request under the Freedom of Information Act 1982...
Document showing the absolute risk reduction of each covid vaccine
Response by Therapeutic Goods Administration to Jaay-H on .

Partially successful.

Dear Jaay-H, Thank you for your email below dated 27 July 2021 in which you sought access to the following documents under the Freedom of Information...
PCR Tests
Response by Therapeutic Goods Administration to Christopher Thanos on .

Information not held.

Dear Mr Thanos, I refer to your request below received by the Department of Health (the department) on 4 August 2021, seeking access under the Freedo...
Experimental Vaccine Consent Form
Response by Therapeutic Goods Administration to Phillip Sweeney on .

Successful.

Attention:  Phillip Sweeney   We refer to your request received by the Department of Health on 17 July 2021 as follows:   a copy of the consen...
Do COVID-19 'vaccines' prevent infection and the transmission of the virus to others?
Response by Therapeutic Goods Administration to Phillip Sweeney on .

Successful.

Good afternoon Phillip, Please see attached decision notice regarding your request. Freedom of Information Therapeutic Goods Administration Australi...
Documents comparing health outcomes between children that have received vaccines and children that have never received any vaccines
Request sent to Therapeutic Goods Administration by Jaay-H on .

Information not held.

Under the FOI Act, I would like to ask for the documents comparing health outcomes between children that have received vaccines and children that ha...
Tranylcypromine Outlook
Response by Therapeutic Goods Administration to Megs on .

Waiting clarification.

Dear Megs   Could you please respond to my email below and provide evidence of financial hardship should you wish for the decision maker to consid...
Countries of vaccine manufacture
Response by Therapeutic Goods Administration to Shanna Miller on .

Refused.

Dear Ms Miller   Please find attached correspondence in relation to your Freedom of Information request.   Consultation As your request rela...
Communication between TGA and Minister Hunt on a TGA application to exempt HTPs from the poisons schedule
Response by Therapeutic Goods Administration to Brenda Sturdy on .

Refused.

Dear Ms Sturdy   Please find attached correspondence in relation to your Freedom of Information request.   Consultation As your request rela...
Adverse Incident Reports Involving ECT Machines
Response by Therapeutic Goods Administration to Nicholas Webb on .

Refused.

Dear Mr Webb   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, please do...
Hepatitis B vaccines placebo control and AAHS safety studies
Response by Therapeutic Goods Administration to Phillip Hayes on .

Information not held.

Dear Mr Hayes I refer to your request dated 3 January 2020 under the Freedom of Information Act 1982 (FOI Act) for:   “1. Documentation that dem...
Evaluation documents relating to licensing of certain vaccines
Response by Therapeutic Goods Administration to KBurgess on .

Partially successful.

Dear Ms McKerrell   Thank you for your response of 5 January 2020, and please accept our apologies for the delay.   At the outset, I regret th...
No placebo in vaccine studies
Response by Therapeutic Goods Administration to Phillip Hayes on .

Information not held.

Dear Mr Hayes   Thank you for your email.   On 11 December 2019 you were advised by email that initial searches indicated that your Freedom of...
Copies of documents relating to correspondence between the TGA and UCB Australia in 2018 containing the keywords ‘Sodium Oxybate’ and/or ‘Xyrem’
Response by Therapeutic Goods Administration to Anne Williams on .

Successful.

Dear Ms Williams   As the TGA has received the balance of the amount owing for the processing of your request I am now releasing the documents to...
Reports used for the approval of Diphtheria, Pertussis and Tetanus vaccines.
Response by Therapeutic Goods Administration to Shanna Miller on .

Refused.

Dear Ms Miller   Please find attached correspondence in relation to your Freedom of Information request.   As set out in the attached correspo...
License products: opioid medicines
Response by Therapeutic Goods Administration to Georgia Richards on .

Successful.

Dear Ms Richards   Thank you for your FOI request of 6 May 2019.   We recommend you search the Australian Register of Therapeutic Goods (ARTG)...
Mefloquine and doxycycline malaria prophylaxis in Australian soldiers in East Timor, April 2001–October 2001 and October 2001–May 2002
Response by Therapeutic Goods Administration to Scott McCormick on .

Information not held.

Dear Mr McCormick   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, pleas...
Adverse event reports for mefloquine hydrochloride ('Lariam') between 1980 ans 2018
Response by Therapeutic Goods Administration to Jane Quinn on .

Successful.

Dear Dr Quinn   Please find attached correspondence in relation to your Freedom of Information request.   If you have any questions, please do...
Information related to the NCE approval of tafenoquine succinate
Response by Therapeutic Goods Administration to Jane Quinn on .

Partially successful.

Dear Dr Quinn   I am resending the email below as we received an email stating that there was an issue delivering the email.   Kind regards...
Pre-registration and registration application information pertaining to the registration of tafenoquine succinate.
Response by Therapeutic Goods Administration to Jane Quinn on .

Refused.

Dear Miss Quinn, We refer to your email 17 April 2018 (copy below). We advise that the TGA does not utilise the right to know platform outlined in yo...
applications to import unapproved therapeutic goods under TGA's Special Access Scheme, 2015 to mid-2017
Request to Therapeutic Goods Administration by faustus. Annotated by faustus on .

Refused.

Noting the fees quoted in previous FOI attempts, I structured my request in a manner that would obviate any fees. Yet, in spite of this approach, I was...
Registration information and amendments to dosage of mefloquine ('Lariam')
Response by Therapeutic Goods Administration to Jane Quinn on .

Successful.

Dear Ms Quinn,   Please find attached the Notice of Decision in relation to your Freedom of Information request.   Kind regards   Freedom...
Documents Relating to Applications for the Registration of Tafenoquine for Malaria Chemoprophylaxis
Response by Therapeutic Goods Administration to Stuart McCarthy on .

Refused.

Dear Mr McCarthy,   Please find attached correspondence in relation to your FOI request.   Kind regards Jacki   Freedom of Information (...

Only requests made using Right to Know are shown. ?